when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

GLP-1 receptor · news · pharmadog

← back to GLP-1 receptor

News · GLP-1 receptor

341 stories

Jul 8, 26STAT+: Europe will accelerate its review of RevMed’s drugstat

Jul 7, 26Kailera says obesity pill succeeds in late-stage trial in Chinabiopharma dive

Jul 7, 26Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trialsendpoints

Jul 7, 26STAT+: ‘Secret shopper’ study probes GLP-1 telehealth sitesstat

Jul 7, 26STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and morestat

Jul 7, 26Ebola outbreak exposes a fractured outbreak response systemstat

Jul 6, 26Obamacare rolls shrank dramatically in many states over the past year, new federal data showsstat

Jul 6, 26New CDER appointment elevates longtime GLP-1 reviewerendpoints

Jul 6, 26STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversightstat

Jul 6, 26Opinion: The smart way to regulate the peptide boomstat

Jul 6, 26What does content creation do to mental health?stat

Jul 2, 26STAT+: Elevance sues government over $115 million tied to Medicare Advantage star ratingsstat

Jul 2, 26BrightGene looks to the West as obesity shot nears China approvalendpoints

Jul 1, 26Statins and blood pressure drugs changing health risks of obesity, study suggestsstat

Jun 30, 26STAT+: Investors double down on Bain-backed startupstat

Jun 30, 26STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordiskstat

Jun 29, 26STAT+: 26 states sue to block Medicaid work requirementsstat

Jun 29, 26STAT+: Unredacted comments from California hospital lawsuits show stunning admissions and a ‘forced’ McKinsey collaborationstat

Jun 29, 26STAT+: Longevity, wellness physicians named to panel advising FDA on peptidesstat

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 20, 26Opinion: Why the space in ‘health care’ mattersstat

Jun 18, 26STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversystat

Jun 18, 26STAT+: Cambrian’s experimental longevity drug mimics exercisestat

Jun 18, 26Prepping for peptidesendpoints

Jun 18, 26How many Americans can afford high-quality health care? A new poll finds the number has fallenstat

Jun 18, 26Super-potent synthetic opioids called nitazenes are spreading across the U.S.stat

Jun 18, 26New infant botulism outbreak puts fancy formulas under scrutinystat

Jun 18, 26What’s next for GLP-1 weight loss drugs?stat

Jun 17, 26FDA warns telehealth companies over compounded GLP-1sendpoints

Jun 17, 26For biopharma manufacturing at speed and scale, the future is flexiblefiercebiotech

← prevpage 9 of 12next →